[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism].
Reggiani, K
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]. [electronic resource] - L'Encephale - 62-7 p. digital
Publication Type: English Abstract; Journal Article
0013-7006
Adolescent
Adult
Antidepressive Agents--adverse effects
Antipsychotic Agents--adverse effects
Basal Ganglia Diseases--chemically induced
Brain--physiology
Cytochrome P-450 CYP2D6--genetics
Female
Gene Expression--genetics
Genetic Predisposition to Disease
Humans
Male
Mental Disorders--drug therapy
Middle Aged
Polymorphism, Genetic--genetics
Risk Factors
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]. [electronic resource] - L'Encephale - 62-7 p. digital
Publication Type: English Abstract; Journal Article
0013-7006
Adolescent
Adult
Antidepressive Agents--adverse effects
Antipsychotic Agents--adverse effects
Basal Ganglia Diseases--chemically induced
Brain--physiology
Cytochrome P-450 CYP2D6--genetics
Female
Gene Expression--genetics
Genetic Predisposition to Disease
Humans
Male
Mental Disorders--drug therapy
Middle Aged
Polymorphism, Genetic--genetics
Risk Factors